Shanghai Aladdin Biochemical Technology Co.,Ltd. Share Price
Equities
688179
CNE100005XD0
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.1 CNY | -0.80% | +0.54% | -18.89% |
Sales 2024 * | 51Cr 7.07Cr 590.12Cr | Sales 2025 * | 66Cr 9.13Cr 761.85Cr | Capitalization | 307.9Cr 43Cr 3.55TCr |
---|---|---|---|---|---|
Net income 2024 * | 18Cr 2.44Cr 204Cr | Net income 2025 * | 23Cr 3.15Cr 262.79Cr | EV / Sales 2024 * | 6.01 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 4.66 x |
P/E ratio 2024 * |
12.4
x | P/E ratio 2025 * |
9.65
x | Employees | 566 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.04% |
1 day | -0.80% | ||
1 week | +0.54% | ||
Current month | -3.06% | ||
1 month | -3.06% | ||
3 months | +8.82% | ||
6 months | -24.53% | ||
Current year | -18.89% |
Managers | Title | Age | Since |
---|---|---|---|
Jiu Zhen Xu
CEO | Chief Executive Officer | 58 | - |
Hong Bao Shen
DFI | Director of Finance/CFO | 41 | - |
Wei Yu Gu
DFI | Director of Finance/CFO | 49 | 01/11/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xin An Zhao
BRD | Director/Board Member | 55 | 01/13/01 |
Jiu Zhen Xu
CEO | Chief Executive Officer | 58 | - |
Kun Wang
ADM | Chief Administrative Officer | 44 | 01/11/01 |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 11.1 | -0.80% | 2,466,688 |
29/24/29 | 11.19 | +2.38% | 3,203,016 |
28/24/28 | 10.93 | -0.82% | 1,875,201 |
27/24/27 | 11.02 | +2.13% | 2,326,402 |
24/24/24 | 10.79 | -2.26% | 2,723,780 |
End-of-day quote Shanghai S.E., May 30, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.89% | 43Cr | |
+52.36% | 5.81TCr | |
-3.86% | 4.05TCr | |
+36.78% | 3.9TCr | |
-12.01% | 2.66TCr | |
+14.13% | 2.67TCr | |
-21.62% | 1.9TCr | |
+0.21% | 1.22TCr | |
+25.96% | 1.19TCr | |
+23.02% | 1.2TCr |
- Stock Market
- Equities
- 688179 Stock